Marizyme, Inc.

Marizyme, Inc.

MRZM - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$39.54K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Marizyme, Inc.Marizyme, Inc.0-142%--1.7

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$39,538.00
Enterprise Value$26.63 Million
Earnings per Share$-1.53
Beta0.86
Outstanding Shares131,793,000

Return

Return on Equity141.74%ROE
Return on Assets-103.62%
Return on Invested Capital138.77%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue145.21
Enterprise Value to EBIT-2.2
Enterprise Value to Net Income-2
Total Debt to Enterprise1
Debt to Equity-1.72Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Marizyme, Inc.

13 employees
CEO: David L. Barthel

Marizyme, Inc. is a life sciences company primarily engaged in bringing innovative medical technologies from development to market. Its offerings include DuraGraft, a unique single-application treatment administered during vascular and b...